Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2025-12-25 @ 7:06 PM
Study NCT ID:
NCT01601704
Status:
TERMINATED
Last Update Posted:
2017-02-27
First Post:
2012-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Sponsor:
Orexigen Therapeutics, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NB-CVOT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None